Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02799394
Other study ID # N- 20140100-1
Secondary ID
Status Completed
Phase N/A
First received June 10, 2016
Last updated January 27, 2018
Start date June 2016
Est. completion date December 2017

Study information

Verified date January 2018
Source Aalborg University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate the effect of activity modification, exercises and a gradual return to sport in adolescents (age 10-14) with Osgood Schlatter disease. The primary outcome is self-reported recovery on a 7-point Likert scale at 3 months. Secondary endpoints include 4 and 8 weeks and 6 and 12 months after inclusion into the project. The adolescents will be recruited from primary schools, general practitioners and through online advertising on Facebook.


Read more »

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Activity modification, exercises and gradual return to sport


Locations

Country Name City State
Denmark Aalborg Universitetshospital Aalborg The North Denmark Region
Denmark Hvidovre-Amager Hospital Hvidovre

Sponsors (1)

Lead Sponsor Collaborator
Aalborg University

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Self-reported recovery on a 7-point Likert scale 3 months
Secondary Self-reported recovery on a 7-point Likert scale 4 and 8 weeks + 6 and 12 months after inclusion.
Secondary Self-report questionnaire "Knee Injury and Osteoarthritis Outcome Score" 4, 8 and 12 weeks + 6 and 12 months after inclusion.
Secondary Isometric hip and knee extension strength assessed using a strap-mounted dynamometer 4, 8 and 12 weeks after inclusion.
Secondary Pressure pain thresholds at tuberositas patella, center of patella and lateral elbow assessed by a hand held pressure algometer. 4, 8 and 12 weeks after inclusion.
Secondary Thigh circumference measured using tape measure. 4, 8 and 12 weeks after inclusion.
Secondary Vertical jump for height [calculated as the difference between reach height and maximal jump height. This will be measured using a ruler] 4, 8 and 12 weeks after inclusion.
Secondary Single leg jump for distance (defined as the maximal length the subject can jump on one leg. Measured using a ruler). 4, 8 and 12 weeks after inclusion.
Secondary Flexibility of the hamstrings and quadriceps [measured using goniometer]. 4, 8 and 12 weeks after inclusion.
See also
  Status Clinical Trial Phase
Completed NCT02824172 - Treatment of the Osgood Schlatter N/A